Insulin resistance, neuroinflammation, and Alzheimer's disease

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1515/revneuro-2013-0050
AuthorSearch for: 1; Search for: 1; Search for: ; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Subjectamyloid; insulin; tau protein; amyloid precursor protein; age; Alzheimer disease; autophosphorylation; central nervous system; degenerative disease; drug targeting; insulin resistance; nerve degeneration; nervous system inflammation; neurofibrillary tangle; neurotoxicity; risk factor; inflammation; metabolism; signal transduction; Inflammation
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NPARC number21275594
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier23e8fc3d-827e-4d6c-92ff-af42e8e9b868
Record created2015-07-14
Record modified2020-04-22
Date modified: